Brief: Sigilon Therapeutics Reports Q1 2023 Financial Results And Business Highlights
09/05/2023 13:13
May 9 (Reuters) - Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* SIGILON THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.23
* SIGILON THERAPEUTICS INC - PIPELINE PRIORITIZATION EXTENDS
ANTICIPATED CASH RUNWAY INTO 2025
* SIGILON THERAPEUTICS INC - SIG-002 TRANSITIONING TO
IND-ENABLING
AND NHP STUDIES IN SECOND HALF OF 2023
Source text for Eikon: ID:nGNXbP9lmq
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx